Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


03.04.2017

1 Acta Med Litu
1 Acta Radiol
1 Am J Cancer Res
2 Am J Transl Res
1 Appl Immunohistochem Mol Morphol
1 Appl Nurs Res
1 Arch Gynecol Obstet
2 Asian Pac J Cancer Prev
1 BMJ
1 Brachytherapy
1 Braz J Med Biol Res
1 Bull Cancer
1 Cancer
1 Cancer Res Treat
1 Cell Death Dis
1 Cell Stress Chaperones
1 Clin Epigenetics
1 Clin Oncol (R Coll Radiol)
1 Clinics (Sao Paulo)
1 Dermatol Ther
1 Diagn Cytopathol
1 Eur J Cancer
1 Eur J Cancer Prev
1 Exp Oncol
1 Gene
1 Genet Mol Res
1 Gynecol Oncol Rep
1 Gynecol Oncol Res Pract
1 Hum Immunol
2 Int J Gynecol Cancer
1 Int J Oncol
1 J Contemp Brachytherapy
1 J Immunol Res
1 J Pediatr Adolesc Gynecol
1 JMM Case Rep
1 Jpn J Clin Oncol
1 Med Sci Monit
1 Med Sci Monit Basic Res
1 Mol Pharm
1 Obstet Gynecol Sci
1 Obstet Gynecol Surv
1 Onco Targets Ther
2 Oncoimmunology
2 Pan Afr Med J
2 Phys Med
1 Radiat Oncol
1 Radiother Oncol
1 Reprod Health
1 Rev Bras Ginecol Obstet
1 Sci Rep
1 Semin Oncol Nurs
1 Strahlenther Onkol
1 Surg Pathol Clin
1 Tohoku J Exp Med
2 Tumour Biol
1 Zhonghua Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Med Litu

  1. RUTA K, Jolita R, Ingrida L, Nadezda L, et al
    Increasing attendance in a cervical cancer screening programme by personal invitation: experience of a Lithuanian primary health care centre.
    Acta Med Litu. 2016;23:180-184.
    PubMed     Text format     Abstract available


    Acta Radiol

  2. ERBAY G, Onal C, Karadeli E, Guler OC, et al
    Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
    Acta Radiol. 2017;58:481-488.
    PubMed     Text format     Abstract available


    Am J Cancer Res

  3. LI J, Meng X, Hu J, Zhang Y, et al
    Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1.
    Am J Cancer Res. 2017;7:234-244.
    PubMed     Text format     Abstract available


    Am J Transl Res

  4. HOU J, Yang H, Huang X, Leng X, et al
    N-WASP promotes invasion and migration of cervical cancer cells through regulating p38 MAPKs signaling pathway.
    Am J Transl Res. 2017;9:403-415.
    PubMed     Text format     Abstract available

  5. LIN L, Zhao W, Sun B, Wang X, et al
    Overexpression of TRIM24 is correlated with the progression of human cervical cancer.
    Am J Transl Res. 2017;9:620-628.
    PubMed     Text format     Abstract available


    Appl Immunohistochem Mol Morphol

  6. ZHANG L, Liu Y, Zheng P
    Downregulation of ADAMTS18 May Serve as a Poor Prognostic Biomarker for Cervical Cancer Patients.
    Appl Immunohistochem Mol Morphol. 2017 Mar 30. doi: 10.1097/PAI.0000000000000496
    PubMed     Text format     Abstract available


    Appl Nurs Res

  7. LEE H, Kim M, Allison J, Kiang P, et al
    Development of a theory-guided storytelling narrative intervention to improve HPV vaccination behavior: Save our daughters from cervical cancer.
    Appl Nurs Res. 2017;34:57-61.
    PubMed     Text format    


    Arch Gynecol Obstet

  8. CHATZISTAMATIOU K, Moysiadis T, Angelis E, Kaufmann A, et al
    Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Arch Gynecol Obstet. 2017 Mar 23. doi: 10.1007/s00404-017-4324.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  9. REFAEI M, Dehghan Nayeri N, Khakbazan Z, Pakgohar M, et al
    Cervical Cancer Screening in Iranian Women: Healthcare Practitioner Perceptions and Views
    Asian Pac J Cancer Prev. 2017;18:357-363.
    PubMed     Text format     Abstract available

  10. PRASONGVEJ P, Nanthakomon T, Jaisin K, Chanthasenanont A, et al
    Quality of Life in Cervical Cancer Survivors and Healthy Women: Thai Urban Population Study
    Asian Pac J Cancer Prev. 2017;18:385-389.
    PubMed     Text format     Abstract available


    BMJ

  11. DIJKSTRA MG, van Zummeren M, Rozendaal L, van Kemenade FJ, et al
    Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    BMJ. 2016;355:i4924.
    PubMed     Text format     Abstract available


    Brachytherapy

  12. TRIFILETTI DM, Grover S, Libby B, Showalter TN, et al
    Trends in cervical cancer brachytherapy volume suggest case volume is not the primary driver of poor compliance rates with brachytherapy delivery for locally advanced cervical cancer.
    Brachytherapy. 2017 Mar 20. pii: S1538-4721(17)30043.
    PubMed     Text format     Abstract available


    Braz J Med Biol Res

  13. LI M, Feng YM, Fang SQ
    Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer.
    Braz J Med Biol Res. 2017;50:e5356.
    PubMed     Text format     Abstract available


    Bull Cancer

  14. EISINGER F, Pivot X, Greillier L, Couraud S, et al
    [Cancer screening in France: 10 years of analysis of behaviours by the EDIFICE surveys].
    Bull Cancer. 2017;104:258-266.
    PubMed     Text format     Abstract available


    Cancer

  15. BERMAN TA, Schiller JT
    Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Cancer. 2017 Mar 27. doi: 10.1002/cncr.30588.
    PubMed     Text format     Abstract available


    Cancer Res Treat

  16. LEE TH, Kim W, Shin J, Park EC, et al
    Strategic Distributional Cost-Effectiveness Analysis for Improving National Cancer Screening Uptake in Cervical Cancer: A Focus on Regional Inequality in South Korea.
    Cancer Res Treat. 2017 Mar 30. doi: 10.4143/crt.2016.
    PubMed     Text format     Abstract available


    Cell Death Dis

  17. TAGUCHI Y, Horiuchi Y, Kano F, Murata M, et al
    Novel prosurvival function of Yip1A in human cervical cancer cells: constitutive activation of the IRE1 and PERK pathways of the unfolded protein response.
    Cell Death Dis. 2017;8:e2718.
    PubMed     Text format     Abstract available


    Cell Stress Chaperones

  18. ALVAREZ-OLMEDO DG, Biaggio VS, Koumbadinga GA, Gomez NN, et al
    Recombinant heat shock protein 27 (HSP27/HSPB1) protects against cadmium-induced oxidative stress and toxicity in human cervical cancer cells.
    Cell Stress Chaperones. 2017 Mar 24. doi: 10.1007/s12192-017-0768.
    PubMed     Text format     Abstract available


    Clin Epigenetics

  19. THANGAVELU PU, Krenacs T, Dray E, Duijf PH, et al
    In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion.
    Clin Epigenetics. 2016;8:120.
    PubMed     Text format     Abstract available


    Clin Oncol (R Coll Radiol)

  20. COSSAR LH, Schache AG, Risk JM, Sacco JJ, et al
    Modulating the DNA Damage Response to Improve Treatment Response in Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2017 Mar 20. pii: S0936-6555(17)30119.
    PubMed     Text format     Abstract available


    Clinics (Sao Paulo)

  21. BRAZ NS, Lorenzi NP, Sorpreso IC, Aguiar LM, et al
    The acceptability of vaginal smear self-collection for screening for cervical cancer: a systematic review.
    Clinics (Sao Paulo). 2017;72:183-187.
    PubMed     Text format     Abstract available


    Dermatol Ther

  22. ROB F, Tachezy R, Pichlik T, Rob L, et al
    High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
    Dermatol Ther. 2017;30.
    PubMed     Text format     Abstract available


    Diagn Cytopathol

  23. KIR G, Sarbay BC, Seneldir H
    The significance of parakeratosis alone in cervicovaginal cytology of turkish women.
    Diagn Cytopathol. 2017;45:297-302.
    PubMed     Text format     Abstract available


    Eur J Cancer

  24. LYNGE E, Lonnberg S, Tornberg S
    Cervical cancer incidence in elderly women-biology or screening history?
    Eur J Cancer. 2017;74:82-88.
    PubMed     Text format     Abstract available


    Eur J Cancer Prev

  25. HAMERS FF, Duport N, Beltzer N
    Population-based organized cervical cancer screening pilot program in France.
    Eur J Cancer Prev. 2017 Mar 30. doi: 10.1097/CEJ.0000000000000365.
    PubMed     Text format     Abstract available


    Exp Oncol

  26. SATINDER K, Sobti RC, Pushpinder K
    Impact of single nucleotide polymorphism in chemical metabolizing genes and exposure to wood smoke on risk of cervical cancer in North-Indian women.
    Exp Oncol. 2017;39:69-74.
    PubMed     Text format     Abstract available


    Gene

  27. NIU G, Wang D, Pei Y, Sun L, et al
    Systematic identification of key genes and pathways in the development of invasive cervical cancer.
    Gene. 2017 Mar 21. pii: S0378-1119(17)30176-2. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    Genet Mol Res

  28. SANTOS FILHO MV, Gurgel AP, Lobo CD, Freitas AC, et al
    Prevalence of human papillomavirus (HPV), distribution of HPV types, and risk factors for infection in HPV-positive women.
    Genet Mol Res. 2016;15.
    PubMed     Text format     Abstract available


    Gynecol Oncol Rep

  29. MAZA M, Alfaro K, Garai J, Velado MM, et al
    Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country.
    Gynecol Oncol Rep. 2017;20:58-61.
    PubMed     Text format     Abstract available


    Gynecol Oncol Res Pract

  30. OBIRI-YEBOAH D, Adu-Sarkodie Y, Djigma F, Akakpo K, et al
    Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana.
    Gynecol Oncol Res Pract. 2017;4:8.
    PubMed     Text format     Abstract available


    Hum Immunol

  31. CORDEIRO JC, da Silva JS, Roxo VS, da Graca Bicalho M, et al
    A pilot study on Hla-G locus control region haplotypes and cervical intraepithelial neoplasias.
    Hum Immunol. 2017;78:281-286.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  32. ZHANG Y, Gao H, Gao X, Huang S, et al
    Elevated Expression of Kin17 in Cervical Cancer and Its Association With Cancer Cell Proliferation and Invasion.
    Int J Gynecol Cancer. 2017 Mar 24. doi: 10.1097/IGC.0000000000000928.
    PubMed     Text format     Abstract available

  33. WANG Q, Wei Y, Zhang J
    Combined Knockdown of D-dopachrome Tautomerase and Migration Inhibitory Factor Inhibits the Proliferation, Migration, and Invasion in Human Cervical Cancer.
    Int J Gynecol Cancer. 2017 Mar 23. doi: 10.1097/IGC.0000000000000951.
    PubMed     Text format     Abstract available


    Int J Oncol

  34. SU K, Wang CF, Zhang Y, Cai YJ, et al
    miR-940 upregulation contributes to human cervical cancer progression through p27 and PTEN inhibition.
    Int J Oncol. 2017 Mar 7. doi: 10.3892/ijo.2017.3897.
    PubMed     Text format     Abstract available


    J Contemp Brachytherapy

  35. KARLSSON L, Thunberg P, With A, Mordhorst LB, et al
    3D image-based adapted high-dose-rate brachytherapy in cervical cancer with and without interstitial needles: measurement of applicator shift between imaging and dose delivery.
    J Contemp Brachytherapy. 2017;9:52-58.
    PubMed     Text format     Abstract available


    J Immunol Res

  36. MEHTA AM, Mooij M, Brankovic I, Ouburg S, et al
    Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.
    J Immunol Res. 2017;2017:8913860.
    PubMed     Text format     Abstract available


    J Pediatr Adolesc Gynecol

  37. GICHANE MW, Calo WA, McCarthy SH, Walmer KA, et al
    Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program.
    J Pediatr Adolesc Gynecol. 2017;30:96-101.
    PubMed     Text format     Abstract available


    JMM Case Rep

  38. SINGH MB, Harrington AT
    Pasteurella multocida urinary tract infection in a patient with cervical cancer.
    JMM Case Rep. 2017;4:e005082.
    PubMed     Text format     Abstract available


    Jpn J Clin Oncol

  39. SEKI T, Tanabe H, Nagata C, Suzuki J, et al
    Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Jpn J Clin Oncol. 2017;47:32-38.
    PubMed     Text format     Abstract available


    Med Sci Monit

  40. WANG H, Gao W
    DJ-1 Expression in Cervical Carcinoma and its Effects on Cell Viability and Apoptosis.
    Med Sci Monit. 2016;22:2943-9.
    PubMed     Text format     Abstract available


    Med Sci Monit Basic Res

  41. YOUNG J, Yee M, Kim H, Cheung J, et al
    Phototoxicity of Liposomal Zn- and Al-phthalocyanine Against Cervical and Oral Squamous Cell Carcinoma Cells In Vitro.
    Med Sci Monit Basic Res. 2016;22:156-164.
    PubMed     Text format     Abstract available


    Mol Pharm

  42. LECHANTEUR A, Furst T, Evrard B, Delvenne P, et al
    Promoting vaginal distribution of E7 and MCL-1 siRNA-silencing nanoparticles for cervical cancer treatment.
    Mol Pharm. 2017 Mar 28. doi: 10.1021/acs.molpharmaceut.6b01154.
    PubMed     Text format     Abstract available


    Obstet Gynecol Sci

  43. YEON J, Jung YW, Yang SS, Kang BH, et al
    Lower limb compartment syndrome by reperfusion injury after treatment of arterial thrombosis post-laparoscopic radical hysterectomy and pelvic lymph node dissection for cervical cancer.
    Obstet Gynecol Sci. 2017;60:223-226.
    PubMed     Text format     Abstract available


    Obstet Gynecol Surv

  44. CORDEIRO CN, Gemignani ML
    Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety.
    Obstet Gynecol Surv. 2017;72:184-193.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  45. PHUAH NH, Azmi MN, Awang K, Nagoor NH, et al
    Suppression of microRNA-629 enhances sensitivity of cervical cancer cells to 1'S-1'-acetoxychavicol acetate via regulating RSU1.
    Onco Targets Ther. 2017;10:1695-1705.
    PubMed     Text format     Abstract available


    Oncoimmunology

  46. VAN MEIR H, Nout RA, Welters MJ, Loof NM, et al
    Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients.
    Oncoimmunology. 2016;6:e1267095.
    PubMed     Text format     Abstract available

  47. BALSAT C, Blacher S, Herfs M, Van de Velde M, et al
    A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancer.
    Oncoimmunology. 2017;6:e1265718.
    PubMed     Text format     Abstract available


    Pan Afr Med J

  48. SAMLALI H, Jouhadi H, Attar H, Sahraoui S, et al
    [A rare cases of rhabdomyosarcoma of the uterine cervix: about a case and review of the literature].
    Pan Afr Med J. 2016;25:166.
    PubMed     Text format     Abstract available

  49. SALEK G, Lalya I, Rahali DM, Dehayni M, et al
    Villoglandular papillary adenocarcinoma: case report.
    Pan Afr Med J. 2016;25:232.
    PubMed     Text format     Abstract available


    Phys Med

  50. O'REILLY FH, Shaw W
    A dosimetric evaluation of IGART strategies for cervix cancer treatment.
    Phys Med. 2016;32:1360-1367.
    PubMed     Text format     Abstract available

  51. SUNG W, Kim JI, Kim HS, Kim HJ, et al
    Performance of the irregular surface compensator compared with four-field box and intensity modulated radiation therapy for gynecologic cancer.
    Phys Med. 2016;32:1537-1542.
    PubMed     Text format     Abstract available


    Radiat Oncol

  52. MENG J, Zhu L, Zhu L, Wang H, et al
    Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Radiat Oncol. 2016;11:141.
    PubMed     Text format     Abstract available


    Radiother Oncol

  53. MENDEZ LC, Weiss Y, D'Souza D, Ravi A, et al
    Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.
    Radiother Oncol. 2017 Mar 25. pii: S0167-8140(17)30101.
    PubMed     Text format     Abstract available


    Reprod Health

  54. MUPANDAWANA ET, Cross R
    Attitudes towards human papillomavirus vaccination among African parents in a city in the north of England: a qualitative study.
    Reprod Health. 2016;13:97.
    PubMed     Text format     Abstract available


    Rev Bras Ginecol Obstet

  55. TIEZZI DG
    Future Perspectives for Uterine Cervical Cancer Treatment based on Integrative Genomic and Molecular Characterizations.
    Rev Bras Ginecol Obstet. 2017 Mar 28. doi: 10.1055/s-0037-1601399.
    PubMed     Text format    


    Sci Rep

  56. LI Y, Ho Kang M, Sup Uhm H, Joon Lee G, et al
    Effects of atmospheric-pressure non-thermal bio-compatible plasma and plasma activated nitric oxide water on cervical cancer cells.
    Sci Rep. 2017;7:45781.
    PubMed     Text format     Abstract available


    Semin Oncol Nurs

  57. KESSLER TA
    Cervical Cancer: Prevention and Early Detection.
    Semin Oncol Nurs. 2017 Mar 23. pii: S0749-2081(17)30015.
    PubMed     Text format     Abstract available


    Strahlenther Onkol

  58. KIM SW, Chun M, Ryu HS, Chang SJ, et al
    Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
    Strahlenther Onkol. 2017 Mar 29. doi: 10.1007/s00066-017-1122.
    PubMed     Text format     Abstract available


    Surg Pathol Clin

  59. MESERVE EE, Nucci MR
    Peutz-Jeghers Syndrome: Pathobiology, Pathologic Manifestations, and Suggestions for Recommending Genetic Testing in Pathology Reports.
    Surg Pathol Clin. 2016;9:243-68.
    PubMed     Text format     Abstract available


    Tohoku J Exp Med

  60. OZAWA N, Ito K, Tase T, Metoki H, et al
    Beneficial Effects of Human Papillomavirus Vaccine for Prevention of Cervical Abnormalities in Miyagi, Japan.
    Tohoku J Exp Med. 2016;240:147-151.
    PubMed     Text format     Abstract available


    Tumour Biol

  61. BHAT S, Kabekkodu SP, Varghese VK, Chakrabarty S, et al
    Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
    Tumour Biol. 2017;39:1010428317694573.
    PubMed     Text format     Abstract available

  62. ZHANG SA, Niyazi HE, Hong W, Tuluwengjiang GL, et al
    Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway.
    Tumour Biol. 2017;39:1010428317692237.
    PubMed     Text format     Abstract available


    Zhonghua Yi Xue Za Zhi

  63. ZHANG JX, Wang SZ, Li B, Zhang ZY, et al
    [Clinical analysis of 23 gynecologic carcinoma patients with brain metastasis].
    Zhonghua Yi Xue Za Zhi. 2016;96:1843-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: